Gates Foundation-Backed i3 to Invest $1.6M in African Health Startups

TLDR
- Investing in Innovation Africa (i3) plans to invest $1.6 million in 15 African healthtech startups
- i3 is supported by the Gates Foundation, Sanofi, and other global health organizations
- Applications close February 28, with winners announced April 30
Investing in Innovation Africa (i3), supported by the Gates Foundation, Sanofi, and other global health organizations, plans to invest $1.6 million in 15 African healthtech startups. Ten early-stage startups will receive $50,000 equity-free grants, while five growth-stage companies will get up to $225,000 each.
Now in its third cohort, i3 targets startups addressing healthcare delivery, pharmacy services, and product distribution. Early-stage applicants must show proven product-market fit and annual revenues above $10,000, while growth-stage startups need national operations and revenues exceeding $500,000.
The initiative comes as African healthtech startups struggle with limited venture capital funding, having secured just $42.2 million—6.5% of total funding—in the first half of 2024. Since its 2021 launch, i3 has invested $3 million in 60 startups across 16 African countries. Selected startups gain financial backing, tailored partnership support, and strategic connections with healthcare organizations. Applications close February 28, with winners announced April 30.
Daba is Africa's leading investment platform for private and public markets. Download here
Key Takeaways
i3’s initiative highlights the critical need for healthtech funding in Africa, where underserved communities face barriers to healthcare access. By combining grants with strategic support, i3 aims to help startups scale commercially and impact local healthcare systems. The program’s emphasis on partnership facilitation, bespoke deal-making, and customer introductions addresses challenges faced by startups in reaching broader markets. With prior beneficiaries like Nigeria’s Wella Health and Healthtracka demonstrating success, i3’s new cohort aims to catalyze innovation across the continent. As venture capital funding declines, such initiatives play a pivotal role in sustaining the growth of Africa’s healthtech ecosystem, ensuring long-term resilience and impact.






Next Frontier
Stay up to date on major news and events in African markets. Delivered weekly.
Pulse54
UDeep-dives into what’s old and new in Africa’s investment landscape. Delivered twice monthly.
Events
Sign up to stay informed about our regular webinars, product launches, and exhibitions.


